Skip to main content
. 2025 Jun 29;17(13):2193. doi: 10.3390/cancers17132193
BPH Benign prostatic hyperplasia
CLIA Clinical laboratory improvement amendments
CPT Current procedural terminology
DRE Digital rectal exam
HEOR Health economic outcomes research
HLPC High likelihood of prostate cancer
HIPAA Health Insurance Portability and Accountability Act
IARC International Agency for Research on Cancer
IHC Immunohistochemistry
IRB Institutional Review Board
LLPC Low likelihood of prostate cancer
mpMRI Multiparametric magnetic resonance imaging
MRI Magnetic resonance imaging
PCa Prostate cancer
PI-RADS Prostate imaging reporting and data system
PLA Proprietary laboratory analysis
PSA Prostate-specific antigen
PSE EpiSwitch® prostate cancer detection
SHAP Shapley additive explanations
TRUS Transrectal ultrasound
TAT Turnaround time
WIRB Western Institutional Review Board
XGBoost Extreme gradient boosting